We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$12.1B
AUM Growth
+$469M
Cap. Flow
-$38.2M
Cap. Flow %
-0.32%
Top 10 Hldgs %
18.63%
Holding
466
New
91
Increased
122
Reduced
152
Closed
85

Top Buys

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$124M
2
FLS icon
Flowserve
FLS
+$81.8M
3
CORZ icon
Core Scientific
CORZ
+$80.1M
4
CCJ icon
Cameco
CCJ
+$66.8M
5
YUMC icon
Yum China
YUMC
+$65.5M

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 22.49%
3 Industrials 17.85%
4 Consumer Discretionary 12.06%
5 Financials 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBLL
276
CeriBell Inc
CBLL
$695M
$7.25M 0.06%
+280,005
New +$7.63M
GAMB
277
DELISTED
Gambling.com
GAMB
$7.17M 0.06%
+509,068
New +$5.99M
CNM icon
278
Core & Main
CNM
$8.56B
$6.94M 0.06%
+136,365
New +$6.42M
WOOF icon
279
Petco
WOOF
$831M
$6.89M 0.06%
+1,807,621
New +$8.17M
LUCK
280
Lucky Strike Entertainment
LUCK
$919M
$6.38M 0.05%
+637,629
New +$7.31M
IONS icon
281
Ionis Pharmaceuticals
IONS
$9.06B
$6.29M 0.05%
180,002
-49,967
-22% -$1.87M
EMXC icon
282
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.6B
$6.2M 0.05%
111,744
GXO icon
283
GXO Logistics
GXO
$5.82B
$6.15M 0.05%
141,320
+26,099
+23% +$1.44M
ORKA
284
Oruka Therapeutics
ORKA
$5.72B
$5.99M 0.05%
308,795
PACK icon
285
Ranpak Holdings
PACK
$465M
$5.87M 0.05%
853,267
-9,769
-1% -$66.9K
PENN icon
286
PENN Entertainment
PENN
$2.67B
$5.8M 0.05%
292,617
+58,328
+25% +$1.15M
CGON icon
287
CG Oncology
CGON
$6.1B
$5.68M 0.05%
197,937
-2,046
-1% -$70K
ESTC icon
288
Elastic
ESTC
$7.15B
$5.63M 0.05%
+56,774
New +$5.25M
KDK
289
Kodiak AI
KDK
$827M
$5.49M 0.05%
500,000
HYAC
290
DELISTED
Haymaker Acquisition Corp 4
HYAC
$5.38M 0.04%
500,000
GLBE icon
291
Global E Online
GLBE
$6.75B
$5.25M 0.04%
+96,249
New +$4.36M
CTSH icon
292
Cognizant
CTSH
$24.9B
$5.1M 0.04%
66,355
-354,372
-84% -$27.7M
ADPT icon
293
Adaptive Biotechnologies
ADPT
$3.68B
$5.07M 0.04%
846,171
+410,877
+94% +$2.27M
LRMR icon
294
Larimar Therapeutics
LRMR
$413M
$4.91M 0.04%
1,269,856
-9,232
-0.7% -$60.9K
IFS icon
295
Intercorp Financial Services
IFS
$6.64B
$4.9M 0.04%
+167,038
New +$4.66M
VSTS icon
296
Vestis
VSTS
$1.89B
$4.88M 0.04%
+320,405
New +$4.82M
DSGN icon
297
Design Therapeutics
DSGN
$797M
$4.79M 0.04%
+776,082
New +$4.49M
NVDA icon
298
NVIDIA
NVDA
$5.01T
$3.71M 0.03%
27,623
-7,670
-22% -$1.06M
KSA icon
299
iShares MSCI Saudi Arabia ETF
KSA
$622M
$3.52M 0.03%
86,232
-52,388
-38% -$2.18M
AAPL icon
300
Apple
AAPL
$4.46T
$3.42M 0.03%
13,662
-8,628
-39% -$2.03M

Similar funds

Driehaus Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Driehaus Capital Management held 466 positions worth $12.1B, up 4% from $11.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Driehaus Capital Management's Q4 2024 filing shows 91 new, 122 increased, 152 reduced and 85 closed positions. Its largest new stake was Yum China: 1,381,026 shares worth $66.5M. The largest sale was Axon Enterprise, an estimated $118M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Driehaus Capital Management's largest Q4 2024 buy was Yum China: 1,381,026 shares worth $66.5M.
  • Driehaus Capital Management added most to Astera Labs in Q4 2024, an estimated $124M increase.
  • Driehaus Capital Management's biggest Q4 2024 reduction was Axon Enterprise, cutting an estimated $118M.
  • Driehaus Capital Management fully exited Wingstop in Q4 2024, selling an estimated $85.3M.
  • Driehaus Capital Management's ten largest holdings make up 19% of its $12.1B portfolio in Q4 2024.
  • Driehaus Capital Management opened 91 new positions and closed 85 in Q4 2024.
  • Driehaus Capital Management's portfolio value rose 4% quarter-over-quarter to $12.1B.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.